Home › Funds › Aequim Alternative Investments LP › GH

Aequim Alternative Investments LP position in GH

GUARDANT HEALTH INC · Health Care

Aequim Alternative Investments LP reported holding 65,000,000 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$190.7M, representing 3.78% of its reported portfolio and ranking #7 among its reported holdings. Aequim Alternative Investments LP has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)65.00M sh
Reported value held$190.66M
Portfolio Weight3.78%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aequim Alternative Investments LP's GH position evolved

Aequim Alternative Investments LP first disclosed a stake in GH in Q3 2023 at 68,500,000 shares (US$47.4M). The position peaked in Q3 2026 at 65,000,000 shares, worth US$190.7M. Across 13 filings, Aequim Alternative Investments LP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 65,000,000 shares valued at US$190.7M — an increase of 27,500,000 shares quarter over quarter.. Notable position changes include a 43% trim in Q2 2025 (shares rose 20% over the following quarter), a 100% increase in Q4 2025 (shares fell 10% over the following quarter), a 73% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 68.50M $47.44M New
Q4 2023 63.50M $44.77M Reduce
Q1 2024 60.00M $41.06M Reduce
Q2 2024 60.00M $46.55M Hold
Q3 2024 60.00M $48.31M Hold
Q4 2024 60.00M $50.55M Hold
Q1 2025 35.00M $36.27M Reduce
Q2 2025 20.00M $23.36M Reduce
Q3 2025 20.00M $26.09M Hold
Q4 2025 40.01M $73.37M Add
Q1 2026 42.50M $71.52M Add
Q2 2026 37.50M $94.41M Reduce
Q3 2026 65.00M $190.66M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GH and 13F data

GH (GUARDANT HEALTH INC) is a Health Care company. 57 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FEDERATED HERMES, INC. (US$445.6M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GH

All GH fund holders →

FAQ

How long has Aequim Alternative Investments LP held GH?

Aequim Alternative Investments LP has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aequim Alternative Investments LP's current position in GH?

As of Q3 2026, Aequim Alternative Investments LP holds 65.00M shares of GH (GUARDANT HEALTH INC), valued at $190.66M, representing 3.78% of its reported portfolio and ranking #7.

Has Aequim Alternative Investments LP been buying or selling GH?

In the latest 13F filing (Q3 2026), Aequim Alternative Investments LP increased its position in GH. The position peaked in Q3 2026 at 65.00M shares.

Which other funds hold GH?

Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., FULLER & THALER ASSET MANAGEMENT, INC., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.